10-K annual report · filed Mar 12, 2026

Astrana Health, Inc. (ASTH) FY2025 10-K Annual Report

Short answer

Astrana Health, Inc. (ASTH) filed its fiscal 2025 10-K annual report with the SEC on Mar 12, 2026. It reported revenue of $3.2B (+56.4% year over year) and net income of $22M.

FY2025 key financial metrics · XBRL

Revenue
$3.2B
+56.4% YoY
Net income
$22M
−47.9% YoY
Operating margin
2.5%
−1.9 pp YoY
EPS (diluted)
$0.46
−48.9% YoY
ROE
2.9%
−3.2 pp YoY
Operating cash flow
$115M
+119.5% YoY

Source: XBRL data from the Astrana Health, Inc. (ASTH) FY2025 10-K on SEC EDGAR. USD.

Astrana Health, Inc. FY2025 10-K analysis

AI summary of each section, grounded in the filing text

Business Overview

  • Core business: Physician-centric, technology-powered, risk-bearing healthcare platform focused on value-based care delivery and coordination for 1.6 million patients
  • New emphasis on expanded Care Enablement segment integrating clinical, operational, financial, and administrative data via proprietary technology suite
  • Strategic shift to assume full financial risk through California Restricted Knox-Keene licensed health plans (RKKs) for broader professional and institutional risk management
  • Workforce growth stable with approximately 3,000 employees as of December 31, 2025, supporting over 20,000 contracted physicians in integrated network
  • Noteworthy expansion of employee development programs and increased community engagement including donations and volunteerism in 2025

Management Discussion & Analysis

  • Revenue $3.18B in 2025, up $1.15B vs $2.03B in 2024, ~56% YoY growth driven by acquisitions and organic growth
  • Adjusted EBITDA $205.4M, up from $170.4M in 2024, margin decreased to 6% from 8% YoY
  • Best segment: Prospect acquisition contributed significantly; worst unclear due to consolidated data only
  • Free cash flow $104.5M vs $44.2M prior year; $15.4M share repurchases, $7.9M dividends, $10.1M capex in 2025
  • Management highlights liquidity with $429.5M cash, $1.05B total debt, completed Prospect acquisition funded by $707.3M drawdown; sees sufficient liquidity for next 12 months

Generated from the filing text; verify against the original. How to read a 10-K

Ask about this 10-K

Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.